StageWise Strategies Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that StageWise Strategies Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $95.4K | Dec 16, 2025 |
| FY2025 | Sep 30, 2024 | $9.0K | Dec 16, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $95.4K | Dec 16, 2025 |
| FY2025 | Sep 30, 2024 | $9.0K | Dec 16, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($74.8K) | Dec 16, 2025 |
| FY2025 | Sep 30, 2024 | ($30.6K) | Dec 16, 2025 |
| FY2024 | Sep 30, 2023 | ($7.0K) | Dec 30, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($74.8K) | Dec 16, 2025 |
| FY2025 | Sep 30, 2024 | ($30.6K) | Dec 16, 2025 |
| FY2024 | Sep 30, 2023 | ($7.0K) | Dec 30, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2024 | ($12.2K) | Dec 30, 2024 |
| FY2024 | Sep 30, 2023 | $11.4K | Dec 30, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $164.9K | Dec 16, 2025 |
| FY2025 | Sep 30, 2024 | $115.7K | Dec 16, 2025 |
| FY2024 | Sep 30, 2023 | $29.4K | Dec 30, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $241.9K | Dec 16, 2025 |
| FY2025 | Sep 30, 2024 | $145.3K | Dec 16, 2025 |
| FY2024 | Sep 30, 2023 | $32.4K | Dec 30, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($77.0K) | Dec 16, 2025 |
| FY2025 | Sep 30, 2024 | ($29.6K) | Dec 16, 2025 |
| FY2025 | Sep 30, 2023 | ($3.0K) | Dec 16, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($112.4K) | Dec 16, 2025 |
| FY2025 | Sep 30, 2024 | ($37.6K) | Dec 16, 2025 |
| FY2024 | Sep 30, 2023 | ($7.0K) | Dec 30, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $4.6K | Dec 16, 2025 |
| FY2025 | Sep 30, 2024 | $11.3K | Dec 16, 2025 |
| FY2024 | Sep 30, 2023 | $610 | Dec 30, 2024 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2024 | $121.8K | Dec 30, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Dec 16, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Dec 16, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Dec 30, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 5.04M | Dec 16, 2025 |
| FY2024 | Sep 30, 2024 | 4.13M | Dec 30, 2024 |
| FY2024 | Sep 30, 2023 | 4.00M | Dec 30, 2024 |